Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer

被引：0
|
作者：
Hakon Blomstrand
Ursula Scheibling
Charlotte Bratthäll
Henrik Green
Nils O. Elander
机构：
[1] Ryhov County Hospital,Department of Oncology
[2] Linköping University,Division of Oncology, Department of clinical and experimental medicine, Faculty of medicine and health sciences
[3] Kalmar County Hospital,Department of Oncology
[4] Linköping University,Division of Drug Research, Department of Medical Health Sciences
[5] Department of Forensic Genetics and Forensic Toxicology,undefined
[6] National Board of Forensic Medicine,undefined
来源：
BMC Cancer | / 19卷
关键词：
Pancreatic cancer; Chemotherapy; Gemcitabine; Nab-paclitaxel; Bone marrow toxicity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Gemcitabine plus nab-paclitaxel for locally advanced or borderline resectable pancreatic cancer
    Akiko Tsujimoto
    Kentaro Sudo
    Kazuyoshi Nakamura
    Emiri Kita
    Ryusuke Hara
    Wataru Takayama
    Hiroshi Ishii
    Taketo Yamaguchi
    Scientific Reports, 9
  • [32] Real-world comparative effectiveness of nab-paclitaxel plus gemcitabine versus FOLFIRINOX in advanced pancreatic cancer: a systematic review
    Chiorean, Elena Gabriela
    Cheung, Winston Y.
    Giordano, Guido
    Kim, George
    Al-Batran, Salah-Eddin
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [33] Real-world experience with FOLFIRINOX and gemcitabine plus nab-paclitaxel in the treatment of pancreatic cancer in Japan
    Maeda, O.
    Yokoyama, Y.
    Yamaguchi, J.
    Ota, A.
    Matsuoka, A.
    Morita, S.
    Inoue, M.
    Mizutani, T.
    Shimokata, T.
    Urakawa, H.
    Mitsuma, A.
    Nagino, M.
    Ando, Y.
    ANNALS OF ONCOLOGY, 2017, 28 : 69 - 69
  • [34] A Retrospective Study of Gemcitabine Plus Nab-Paclitaxel for Advanced Pancreatic Cancer Refractory to Gemcitabine Monotherapy
    Nishioka, Mariko
    Okano, Naohiro
    Wakabayashi, Masashi
    Ikeno, Takashi
    Hayashi, Masato
    Mizutani, Tomonori
    Nagashima, Fumio
    Furuse, Junji
    ANTICANCER RESEARCH, 2024, 44 (03) : 1233 - 1239
  • [35] The effectiveness of nab-paclitaxel plus gemcitabine and gemcitabine monotherapy in first-line metastatic pancreatic cancer treatment: A real-world evidence
    Prejac, Juraj
    Hamzic, Dora Tomek
    Librenjak, Niksa
    Gorsic, Irma
    Kekez, Domina
    Plestina, Stjepko
    MEDICINE, 2022, 101 (39) : E30566
  • [36] Combination chemotherapy with gemcitabine and nab-paclitaxel for a metastatic pancreatic ductal adenocarcinoma patient undergoing hemodialysis
    Takashi Kaneko
    Kazuya Sugimori
    Yuichiro Tozuka
    Taito Fukushima
    Kazuya Okada
    Hiroyuki Oka
    Hiroshi Okazaki
    Shin Maeda
    Clinical Journal of Gastroenterology, 2019, 12 : 484 - 489
  • [37] Progressive digital necrosis during gemcitabine/nab-paclitaxel chemotherapy in a patient with pancreatic cancer
    Shimizu, Yuri
    Ohata, Chika
    DERMATOLOGIC THERAPY, 2022, 35 (04)
  • [38] Combination chemotherapy with gemcitabine and nab-paclitaxel for a metastatic pancreatic ductal adenocarcinoma patient undergoing hemodialysis
    Kaneko, Takashi
    Sugimori, Kazuya
    Tozuka, Yuichiro
    Fukushima, Taito
    Okada, Kazuya
    Oka, Hiroyuki
    Okazaki, Hiroshi
    Maeda, Shin
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2019, 12 (05) : 484 - 489
  • [39] Feasibility of Combination Therapy with Nab-paclitaxel Plus Gemcitabine in Patients with Recurrent Pancreatic Cancer
    Kawaida, Hiromichi
    Kono, Hiroshi
    Amemiya, Hidetake
    Saitou, Ryou
    Yamamoto, Atsushi
    Hosomura, Naohiro
    Watanabe, Mitsuaki
    Kimura, Ayako
    Furuya, Shinji
    Shimizu, Hiroki
    Akaike, Hidenori
    Kawaguchi, Yoshihiko
    Sudo, Makoto
    Itakura, Jun
    Hayakawa, Hiroshi
    Shindo, Hiroko
    Takahashi, Ei
    Takano, Shinichi
    Fukasawa, Mitsuharu
    Ichikawa, Shintaro
    Fujii, Hideki
    Ichikawa, Daisuke
    ANTICANCER RESEARCH, 2018, 38 (11) : 6537 - 6542
  • [40] Gemcitabine (Gem) and nab-paclitaxel (nab-P) in patients (pts) with refractory advanced pancreatic cancer
    Palacio, Sofia
    Akunyili, Ikechukwu Immanuel
    Ernani, Vinicius
    Macintyre, Jessica
    Merchan, Jaime R.
    Pollack, Terri
    Reis, Isildinha
    Restrepo, Maria H.
    Lima, Caio Max S. Rocha
    Hosein, Peter Joel
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
12345